Keywords: b-ms, buying, back, billion, shares, bristol-myers, squibb
B-MS buying back $2 billion in shares
Article | 22 September 2000
Bristol-Myers Squibb's board of directors has approved a $2 billionincrease for the company's common stock repurchase program, raising its capacity to $12 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
